Taking hormone therapy drugs for additional five years improves outcomes in breast ca

[News]

Breast cancer patients significantly benefit by taking hormone therapy drugs called aromatase inhibitors for an additional five years, according to a major study presented at the Plenary Session of the American Society of Clinical Oncology annual meeting in Chicago and published in the New England Journal of Medicine.

More... (http://www.news-medical.net/news/20160607/Taking-hormone-therapy-drugs-for-additional-five-years-improves-outcomes-in-breast-cancer-patients.aspx)